Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNIFF Device Study for Intranasal Insulin
NCT03857321Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2019
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in Mild Cognitive Impairment (MCI), Alzheimer's disease (AD), sponsored by Wake Forest University Health Sciences. Started Apr 2019; status: completed.
02
Drugs
regular human insulin
03
Conditions
Mild Cognitive Impairment (MCI)Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03857321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03857321.